The American Diabetes Association (ADA) divides diabetes technology into two basic categories: for administration of insulin, e.g., via insulin pens or pumps, and for the analysis of glucose concentrations, e.g., via glucose meters or continuous glucose monitors (CGM) [1]. The gene discussed is INS; the disease is diabetes mellitus.